The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.
Jan 3, 2022
0
22
The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.
Dec 24, 2021
0
248
The University of Queensland has updated a calculator to help people understand their risk factors for COVID-19 infection and vaccination with the Pfizer vaccine.
Dec 22, 2021
0
2
The World Health Organization on Tuesday authorised its 10th COVID-19 vaccine—Nuvaxovid from US firm Novavax.
Dec 21, 2021
0
7
Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appear strong enough for some of the children.
Dec 17, 2021
0
11
The EU's drug regulator on Thursday allowed member states to use Pfizer's new COVID pill ahead of its formal approval, as an emergency measure to curb an Omicron-fuelled wave.
Dec 16, 2021
0
7
The omicron variant is offering more hints about what it may have in store as it spreads around the globe: A highly transmissible virus that may cause less severe disease, and one that can be slowed—but not stopped—by ...
Dec 14, 2021
0
28
Pfizer said Tuesday that clinical trials confirmed its COVID pill—a new type of treatment that should withstand the mutations seen with the Omicron variant—drastically reduced hospitalizations and deaths among at-risk ...
Dec 14, 2021
0
11
(HealthDay)—Compared to previous coronavirus variants, Omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South Africa's largest health insurer report.
Dec 14, 2021
0
1
(HealthDay)—Booster doses of Pfizer's coronavirus vaccine set recipients up to effectively withstand the ravages of both the Delta and Omicron variants, a group of new studies suggest.
Dec 9, 2021
0
6
